Core Viewpoint - The article emphasizes the significant advancements in China's healthcare insurance system during the "14th Five-Year Plan" period, focusing on improving coverage, reducing medical expenses for citizens, and enhancing the overall quality of healthcare services [1][2]. Group 1: Universal Coverage - The national basic medical insurance coverage rate has stabilized at around 95% during the "14th Five-Year Plan" period, with nearly 20 billion instances of insurance reimbursement expected from 2021 to 2024 [2]. - The introduction of measures such as allowing newborns to enroll in insurance using their birth certificates and expanding the coverage of maternity insurance aims to enhance accessibility [3]. Group 2: Benefit Expansion - By June 2025, approximately 253 million people are projected to participate in maternity insurance, with cumulative expenditures reaching 438.3 billion yuan, benefiting over 96.14 million instances [3]. - Various medical assistance policies have benefited 673 million rural low-income individuals, alleviating medical expenses by over 650 billion yuan [3]. Group 3: Healthcare Service Improvement - The introduction of the "medical insurance wallet" allows insured individuals to transfer personal account funds to family members for medical expenses, breaking provincial limitations [4]. - The number of designated medical institutions has reached 1.1 million, and the total number of drugs in the insurance catalog has reached 3,159, further reducing the financial burden on citizens [5]. Group 4: Technological Advancements - The establishment of a unified national medical insurance information platform has significantly improved service efficiency, enabling cross-province handling of high-frequency matters [6]. - The regulatory framework for medical insurance funds has been fully established, recovering over 100 billion yuan in misused funds [6]. Group 5: Future Outlook - The National Medical Insurance Administration aims to continue managing and utilizing medical insurance funds effectively, supporting the development of the pharmaceutical industry and contributing to the overall health of the population [7].